Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
10 May 2023 |
On P&L |
The Company releases the first quarter 2023 financial results presentation
|
Download |
|
10 May 2023 |
On P&L |
The Company releases the press release related to the first quarter 2023 financial results
|
Download |
|
25 Apr 2023 |
On business and financial situation |
ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE)
|
Download |
|
21 Feb 2023 |
On business and financial situation |
The Company releases the full year 2022 financial results presentation.
|
Download |
|
21 Feb 2023 |
On business and financial situation |
The Company releases the press release related to the full year 2022 financial results.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
25 Feb 2025 |
Annual Report regarding remuneration of the members of the Board of Directors |
ROVI releases the 2024 annual report regarding remuneration of the members of the Board of Directors
|
Download |
|
07 Jan 2025 |
Liquidity and counterparty agreements |
Liquidity contract: transactions conducted in the fourth quarter of 2024
|
Download |
|
07 Nov 2024 |
On P&L |
A correction to the English version of a document is reported.
|
Download |
|
03 Oct 2024 |
Liquidity and counterparty agreements |
Liquidity contract: transactions conducted in the third quarter of 2024
|
Download |
|
12 Sep 2024 |
Other relevant information |
The Company announces the registration in the Commercial Registry of the public deed of reduction of its share capital and the new share capital figure.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
08 Oct 2018 |
Share capital increases and reductions |
Information on the registration in the Commercial Registry of Madrid of the notarial deed regarding the capital increase
|
Download |
|
05 Oct 2018 |
Buy-back programmes, stabilisation and treasury stock |
Information about the possibility that Jefferies International Limited carries out stabilisation transactions within the framework of the capital increase excluding pre-emptive subscription rights of the existing shareholders of Laboratorios Farmacéuticos Rovi, S.A.
|
Download |
|
04 Oct 2018 |
Share capital increases and reductions |
Directors’ Report and Independent Expert Report related to capital increase excluding preferential subscription rights
|
Download |
|
04 Oct 2018 |
Liquidity contracts and specialists |
The Company informs that has temporarily suspended liquidity agreement with JB Capital Markets, Sociedad de Valores, S.A.U.
|
Download |
|
04 Oct 2018 |
Share capital increases and reductions |
Information on price fixing and outcome of the private placement related to capital increase addressed to institutional investors, excluding preferential subscription rights
|
Download |
Pages
